Accredited InvestorsEmployee ShareholdersInstitutionsPrivate Companies Who We Serve Trading and Investing Data Solutions Private Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Browse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunities​Forge DataAnalyze private markets via Forge’s intuitive web application​Forge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All Insights Private Market Reports Market Insights Buying and Selling Pre-IPO​ All Reports​Private Market UpdatesForge Investment OutlookStartup News and Trends​Private Market Data and Analytics​Tech IPO Calendar for 2024​Private Market Explained​Buying Pre-IPO Shares​Selling Pre-IPO SharesGlossaryVideosFAQsInsights About UsLeadershipInvestor RelationsPeople & CultureCareers About
Log InSign Up
Who We Serve
Solutions
Insights
About
Who We Serve
Solutions
Trading and Investing
Institutional Trading
Individual Investing
Data Solutions
Private Asset Custody
Self-Directed IRA
Insights
Private Market Reports
Market Insights
Buying and Selling Pre-IPO​
About
Log In
Sign Up
Secondary Marketplace / Explore Private Companies / Freenome IPO

Freenome IPO

freenome.comHealthcare / BioTech & Pharma

Freenome is a biotechnology company driven to provide the tools needed to detect, treat and prevent cancer using routing blood draw. This company was founded in 2014 by Gabe Otte, Riley Ennis, Charles Roberts and is headquartered in South San Francisco, CA. Freenome combines molecular biology with advanced computational biology and machine learning to help with early cancer detection.

Buy or sell Freenome stock Learn more about Freenome stock
Register for Details

For more details on financing and valuation for Freenome, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Freenome

Forge green plus iconForge green minus icon

Is Freenome a publicly traded company?

Freenome is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

Will Freenome go IPO?

Freenome has not yet filed for an IPO. However, it's important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or through mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.

Forge green plus iconForge green minus icon

What is Freenome's IPO price?

The IPO price for Freenome will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Freenome pre-IPO?

Freenome is privately held company and is not publicly traded, therefor investing in Freenome pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to invest in private companies before their potential IPO. If you are not an accredited investor, discover how to begin the the process to potentially qualify for new investment opportunities.

Forge green plus iconForge green minus icon

What is the value of my Freenome shares?

To determine the value of your Freenome shares, create a free account to gain access to Forge’s platform. Forge Markets contains pricing information for hundreds of pre-IPO companies. A Private Market Specialist will also be available to assist you with any inquiries related to your Freenome shares. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Can you sell Freenome before it goes public?

Yes, you can seek to sell shares in Freenome while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

Forge green plus iconForge green minus icon

What is Freenome's funding to date?

Freenome has raised $1.35B to date.
Forge green plus iconForge green minus icon

When was Freenome founded?

Freenome was founded in 2014.

Who are Freenome's major investors?

Fidelity Investments
Andreessen Horowitz
GV
Polaris Partners
S28 Capital
CRV
Ra Capital Management
Founders Fund
AME Cloud Ventures
T. Rowe Price
ARTIS Ventures
Perceptive Advisors
Kaiser Permanente Ventures
Farallon Capital Management
Rock Springs Capital
Innovation Endeavors
DCVC
StartX (Stanford-StartX Fund)
Janus Henderson Investors
EcoR1 Capital
Logos Capital
Soleus Capital
Sands Capital
Byers Capital
Catalio Capital Management
ArrowMark Partners
Agent Capital
Ridgeback Capital
Longevity Vision Fund
K50 Ventures
Asset Management Ventures
S32
Roche Venture Fund
Verily Life Sciences
Intermountain Ventures
Squarepoint Capital
BrightEdge.

Freenome funding rounds and last known valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
2/15/2024

Series F

 $254MM raised $XXX.XX $XXX.XX
1/11/2022

Series E

 $290MM raised $XXX.XX $XXX.XX
12/7/2021

Series D

 $300MM raised $XXX.XX $XXX.XX
8/26/2020

Series C

 $270MM raised $XXX.XX $XXX.XX
7/24/2019

Series B

 $165MM raised $XXX.XX $XXX.XX
8/28/2017

Series A

 $69.62MM raised $XXX.XX $XXX.XX
6/19/2016

Series Seed-2

 $5.55MM raised $XXX.XX $XXX.XX
5/6/2016

Series Seed-1

 $800.02K raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Private companies exploring an IPO

Cerebras
Sector
Technology Hardware / Computing hardware
Last Round Est. Valuation
$2.87B
CoreWeave
Sector
Enterprise Software / Data Intelligence
Last Round Est. Valuation
$19B
Liquid Death
Sector
FoodTech / Food Products & Services
Last Round Est. Valuation
$1.4B
Vuori
Sector
Consumer & Lifestyle / Clothing, Fashion, Beauty & Apparel
Last Round Est. Valuation
$213.97MM
Cohesity
Sector
Enterprise Software / Data Management/​Storage
Last Round Est. Valuation
$3.4B
Klarna
Sector
FinTech / Lending
Last Round Est. Valuation
$5.41B
Chime
Sector
FinTech / Digital Banking
Last Round Est. Valuation
$24.93B
SKIMS
Sector
Consumer & Lifestyle / Clothing, Fashion, Beauty & Apparel
Last Round Est. Valuation
$4B
See the IPO Calendar
Trending Companies

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.